The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Abstract
Colistin is the last resort for treatment of multidrug-resistant Acinetobacter baumannii. Unfortunately, resistance to colistin has been reported all over the world. The highest resistance rate was reported in Asia, followed by Europe. The heteroresistance rate of A. baumannii to colistin is generally higher than the resistance rate. The mechanism of resistance might be loss of lipopolysaccharide or/and the PmrAB two-component system. Pharmacokinetic/pharmacodynamic studies revealed that colistin monotherapy is unable to prevent resistance, and combination therapy might be the best antimicrobial strategy against colistin-resistant A. baumannii. Colistin/rifampicin and colistin/carbapenem are the most studied combinations that showed promising results in vitro, in vivo and in the clinic. New peptides showing good activity against colistin-resistant A. baumannii are also being investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lim, L. M., Ly, N., Anderson, D., Yang, J. C., Macander, L., Jarkowski, A., Forrest, A., Bulitta, J. B., & Tsuji, B. T. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.12.1279 · Cited by 444
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 382
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Gales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 337
Gunn, J. S. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.03.007 · Cited by 332
Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J.-H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm305 · Cited by 262
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
Moffatt, J. H., Harper, M., Adler, B., Nation, R. L., Li, J., & Boyce, J. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01732-10 · Cited by 196
Gordon, N. C., Png, K., & Wareham, D. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-10 · Cited by 195
Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-07 · Cited by 183
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Dudhani, R. V., Turnidge, J. D., Nation, R. L., & Li, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq226 · Cited by 181
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Prevalence of multidrug-resistant organisms recovered at a military burn center
Keen, E. F., Robinson, B. J., Hospenthal, D. R., Aldous, W. K., Wolf, S. E., Chung, K. K., & Murray, C. K. (2010) · Burns · doi:10.1016/j.burns.2009.10.013 · Cited by 170
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Montero, A., Ariza, J., Corbella, X., Doménech, A., Cabellos, C., Ayats, J., Tubau, F., Borraz, C., & Gudiol, F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh485 · Cited by 158
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Hornsey, M., Ellington, M. J., Doumith, M., Thomas, C. P., Gordon, N. C., Wareham, D. W., Quinn, J. P., Lolans, K., Livermore, D. M., & Woodford, N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq218 · Cited by 146
Tan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
Soon, R. L., Nation, R. L., Cockram, S., Moffatt, J. H., Harper, M., Adler, B., Boyce, J. D., Larson, I. C., & Li, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq422 · Cited by 136
Li, J., Rayner, C. R., Nation, R. L., Deans, R., Boots, R. J., Widdecombe, N., Douglas, A., & Lipman, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4814-4815.2005 · Cited by 133
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Principe, L., D’Arezzo, S., Capone, A., Petrosillo, N., & Visca, P. (2009) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-8-18 · Cited by 128
Hornsey, M., & Wareham, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00230-11 · Cited by 118
Rodríguez, C. H., Bombicino, K. A., Granados, G., Nastro, M., Carlos, V., & Angela, F. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.05.019 · Cited by 116
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Hawley, J. S., Murray, C. K., Griffith, M. E., McElmeel, M. L., Fulcher, L. C., Hospenthal, D. R., & Jorgensen, J. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00858-06 · Cited by 116
Pachón-Ibáñez, M. E., Docobo-Pérez, F., López-Rojas, R., Domínguez-Herrera, J., Me, J.-M., García-Curiel, A., Pichardo, C., Jiménez, L., & Pachón, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00367-09 · Cited by 114
Vila‐Farrés, X., de la Mària, C. G., López-Rojas, R., Pachón, J., Giralt, E., & Vilà, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03581.x · Cited by 100
Extensively Drug-Resistant Acinetobacter baumannii
Doi, Y., Husain, S., Potoski, B. A., McCurry, K. R., & Paterson, D. L. (2009) · Emerging infectious diseases · doi:10.3201/eid1506.081006 · Cited by 99
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
Saugar, J. M., Rodríguez-Hernández, M. J., de la Torre, B. G., Pachón-Ibáñez, M. E., Fernández‐Reyes, M., Andreu, D., Pachón, J., & Rivas, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1251-1256.2006 · Cited by 91
Al‐Sweih, N., Alhubail, M., & Rotimi, V. O. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.1.13 · Cited by 83
Pantopoulou, A., Giamarellos‐Bourboulis, E. J., Raftogannis, M., Τσαγανός, Θ., Dontas, I. A., Koutoukas, P., Baziaka, F., Giamarellou, H., & Perrea, D. N. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.009 · Cited by 77
Santimaleeworagun, W., Wongpoowarak, P., D, P. C. M., Pattharachayakul, S., Tansakul, P., & Garey, K. W. (2011) · PubMed · Cited by 75
Peck, K. R., Kim, M. J., Choi, J. Y., Kim, H. S., Kang, C., Cho, Y. K., Park, D. W., Lee, H. J., Lee, M. S., & Ko, K. S. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.036939-0 · Cited by 70
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones
Rodríguez, C. H., Ambrosio, A. D., Bajuk, M., Spinozzi, M., Nastro, M., Bombicino, K. A., Radice, M. A., Gutkind, G., Vay, C. A., & Famiglietti, A. M. R. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.604 · Cited by 63
Rodríguez-Hernández, M. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl145 · Cited by 57
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis
Fulnecky, E. J., Wright, D., Scheld, W. M., Kanawati, L., & Shoham, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.003 · Cited by 39
Gómez‐Garcés, J. L., Aracil, B., Gil, Y., & Burillo, A. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.267 · Cited by 20
Külah, C., Çelebi, G., Aktaş, E., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.4.390 · Cited by 16
Cited by
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
Metadata
- Authors
- Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-22
- Volume
- 67
- Issue
- 7
- Pages
- 1607-1615
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2161069049
- Cited by
- 557
- References
- 52
- FWCI
- 17.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.